Literature DB >> 15535047

Variability in the PR and RT genes of HIV-1 isolated from recently infected subjects.

Dan Turner1, Ariel Roldan, Bluma Brenner, Daniela Moisi, Jean-Pierre Routy, Mark A Wainberg.   

Abstract

To study variability in reverse transcriptase (RT) and protease (PR) genes of HIV-1 isolated from recently infected patients identified between 1997 and 2003, sequences were obtained on the RT and PR genes of viruses harvested from plasma of 121 non-treated subjects who had undergone primary HIV infection. The degree of dissimilarity between the viruses studied and a reference HIV-1 subtype B strain (LAV-1) was calculated for each of RT and PR by counting all of the nucleotide substitutions that could be identified. Mutations associated with drug resistance were excluded from analysis. We observed a mean percentage of variation in the RT and PR genes of the viruses analysed of 0.42% between the years 1997--2003 (P<0.01). In PR, the mean variation was 0.71% (P<0.05), while that in RT was 0.3% (P<0.05). Increased diversity was also observed among nucleotides conferring amino-acid changes, although no significant differences in patterns of nucleotide substitutions were apparent over the period of analysis. In conclusion, variability in the RT and PR genes of viruses from recently infected patients has increased over time in a manner that is independent of variability attributable to HIV drug resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15535047     DOI: 10.1177/095632020401500504

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  6 in total

1.  Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape.

Authors:  Kristof Theys; Koen Deforche; Gertjan Beheydt; Yves Moreau; Kristel van Laethem; Philippe Lemey; Ricardo J Camacho; Soo-Yon Rhee; Robert W Shafer; Eric Van Wijngaerden; Anne-Mieke Vandamme
Journal:  BMC Bioinformatics       Date:  2010-08-03       Impact factor: 3.169

2.  Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission.

Authors:  Vasudha Sundaravaradan; Tobias Hahn; Nafees Ahmad
Journal:  Retrovirology       Date:  2005-05-26       Impact factor: 4.602

3.  Functional conservation and coherence of HIV-1 subtype A Vpu alleles.

Authors:  Bizhan Romani; Amirarsalan Kavyanifard; Elham Allahbakhshi
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

4.  Functional conservation and coherence of HIV-1 subtype A Vpu alleles.

Authors:  Bizhan Romani; Amirarsalan Kavyanifard; Elham Allahbakhshi
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

5.  Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; Africa Holguín
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

6.  Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.

Authors:  Kristof Theys; Koen Deforche; Jurgen Vercauteren; Pieter Libin; David Amc van de Vijver; Jan Albert; Birgitta Asjö; Claudia Balotta; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Osamah Hamouda; Andrzei Horban; Klaus Korn; Leondios G Kostrikis; Claudia Kücherer; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stockl; Chiara Riva; Lidia Ruiz; Kirsi Liitsola; Jean-Claude Schmit; Rob Schuurman; Anders Sönnerborg; Danica Stanekova; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; Annemarie Mj Wensing; Charles Ab Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2012-10-03       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.